Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures

J Antimicrob Chemother. 2011 Mar;66(3):608-10. doi: 10.1093/jac/dkq512. Epub 2011 Jan 7.

Abstract

Objectives: To estimate the relative fitness differences between glycopeptide-resistant Enterococcus faecium (GREF) and glycopeptide-susceptible E. faecium (GSEF) from yearly surveillance data on the occurrence of GREF in Danish poultry farm environments.

Methods: A population genetic model was adapted to retrospectively estimate the biological fitness cost of acquired resistance. Maximization of a likelihood function was used to predict the longitudinal persistence of acquired resistance.

Results: Our analysis suggests strong selection against GREF following the 1995 ban on the glycopeptide growth promoter avoparcin. However, parameterizing the model with two selection coefficients suggesting a reduced negative effect of the acquired resistance on bacterial fitness over time significantly improved the fit of the model. Our analyses suggest that the acquired glycopeptide resistance will persist for >25 years.

Conclusions: Acquired resistance determinants in commensal E. faecium populations in Danish farm environments are likely to persist for decades, even in the absence of glycopeptide use.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Carrier State / microbiology
  • Carrier State / veterinary*
  • Denmark
  • Enterococcus faecium / growth & development*
  • Glycopeptides / pharmacology
  • Gram-Positive Bacterial Infections / microbiology
  • Gram-Positive Bacterial Infections / veterinary*
  • Poultry / microbiology
  • Vancomycin Resistance*

Substances

  • Anti-Bacterial Agents
  • Glycopeptides